Protagonist Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	209.22	434.43	60	26.58	27.36	28.63	Upgrade
Revenue Growth (YoY)	-35.39%	624.05%	125.72%	-2.84%	-4.44%	12293.07%	Upgrade
Gross Profit	209.22	434.43	60	26.58	27.36	28.63	Upgrade
Selling, General & Admin	42.37	43.46	33.49	31.74	27.2	18.64	Upgrade
Research & Development	147.84	138.13	120.16	126.22	126.01	74.51	Upgrade
Operating Expenses	190.21	181.59	153.65	157.95	153.2	93.14	Upgrade
Operating Income	19.01	252.84	-93.65	-131.37	-125.85	-64.52	Upgrade
Interest Expense	-	-	-	-	-	-0.6	Upgrade
Interest & Investment Income	28.88	26.32	14.9	4.06	0.44	0.9	Upgrade
Currency Exchange Gain (Loss)	0.19	0.25	-0.2	-0.08	-0.15	-0.05	Upgrade
EBT Excluding Unusual Items	48.08	279.41	-78.96	-127.39	-125.55	-64.26	Upgrade
Other Unusual Items	-	-	-	-	-	-0.59	Upgrade
Pretax Income	48.07	279.41	-78.96	-127.39	-125.55	-64.85	Upgrade
Income Tax Expense	2.16	4.22	-	-	-	1.31	Upgrade
Net Income	45.91	275.19	-78.96	-127.39	-125.55	-66.15	Upgrade
Net Income to Common	45.91	275.19	-78.96	-127.39	-125.55	-66.15	Upgrade
Shares Outstanding (Basic)	63	62	57	49	46	34	Upgrade
Shares Outstanding (Diluted)	64	65	57	49	46	34	Upgrade
Shares Change (YoY)	0.97%	14.65%	15.74%	5.87%	34.67%	32.84%	Upgrade
EPS (Basic)	0.73	4.47	-1.39	-2.60	-2.71	-1.92	Upgrade
EPS (Diluted)	0.72	4.23	-1.39	-2.60	-2.71	-1.92	Upgrade
Free Cash Flow	63.71	182.8	-70.85	-108.93	-108.97	-72.96	Upgrade
Free Cash Flow Per Share	0.99	2.81	-1.25	-2.22	-2.35	-2.12	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	9.09%	58.20%	-156.09%	-494.24%	-460.01%	-225.36%	Upgrade
Profit Margin	21.94%	63.34%	-131.59%	-479.26%	-458.94%	-231.07%	Upgrade
Free Cash Flow Margin	30.45%	42.08%	-118.08%	-409.81%	-398.31%	-254.84%	Upgrade
EBITDA	20.03	253.67	-92.68	-130.34	-125.03	-63.57	Upgrade
EBITDA Margin	9.57%	58.39%	-154.46%	-	-	-222.05%	Upgrade
D&A For EBITDA	1.02	0.83	0.98	1.03	0.81	0.95	Upgrade
EBIT	19.01	252.84	-93.65	-131.37	-125.85	-64.52	Upgrade
EBIT Margin	9.09%	58.20%	-156.09%	-	-	-225.36%	Upgrade
Effective Tax Rate	4.50%	1.51%	-	-	-	-	Upgrade

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q